May 20, 2011Journal of Clinical Oncology214 citations
Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: The NCI’s Lung Cancer Mutation Consortium (LCMC).
View Full Paper
Key Points
Key points are not available for this paper at this time.
Abstract
CRA7506 The full, final text of this abstract will be available in Part II of the 2011 Annual Meeting Proceedings, distributed onsite at the Meeting on June 4, 2011, and as a supplement to the June 20, 2011, issue of Journal of Clinical Oncology.
Cite This Study
Kris et al. (2011) studied this question.